Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen
about
Kaposi's Sarcoma Herpesvirus Genome PersistenceActivation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes VirusA Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus InfectionRegulation of Wnt/β-catenin signaling by herpesvirusesKaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infectionProtein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Conservation of complex nuclear localization signals utilizing classical and non-classical nuclear import pathways in LANA homologs of KSHV and RFHVA protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.Phosphorylation of the chromatin binding domain of KSHV LANAKSHV LANA--the master regulator of KSHV latency.Stabilization of Myc through heterotypic poly-ubiquitination by mLANA is critical for γ-herpesvirus lymphoproliferation.The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infectionKaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65.Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins - SUMO and KSHVDetermination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses.Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence.Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta.The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency.The Ubiquitin System and Kaposi's Sarcoma-Associated Herpesvirus.Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseasesThe Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.Kaposi's sarcoma-associated herpesvirus ORF34 is essential for late gene expression and virus production.Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation.The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domainsHelicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity.
P2860
Q26738483-4FA1132F-BE12-4C9D-9DC2-4D2741E59783Q26743368-8ABBA351-F24F-43CB-A00B-0CF7D50B2718Q27468917-28176F95-886E-4584-AC5C-B24664C3C893Q28079414-A8E390E6-F3EA-4F06-99F4-73878AFE5D63Q28396451-46E10C35-EE5E-4B27-837C-C52D0484A4D2Q33282107-4FFDB77F-791A-4C3D-A4AF-1A2574440F10Q33560572-EE7F8512-B512-4738-8D7C-81BED6E3E6F8Q33895240-9CD26537-881B-4DC4-923A-B2948C9FB53CQ34179693-1FE784A0-7169-4786-93AB-6811D368B0D5Q34456086-10AB5D1C-7394-401C-8228-23EDB644AE49Q34774797-1757A8C7-33F1-411C-BA75-FC5688138A7BQ34945490-E4784E5F-77B9-42AD-B01C-B402B7557304Q35077558-22AA4934-9EDF-4186-9E50-DFCFBDB6F633Q35192868-41D536F1-524A-4B43-8FA0-2C60DD7EBE88Q35755464-DC60B7C3-C2D8-472A-8C97-B0D44C7D7E05Q35785433-C42F018E-8AF8-4253-BB3A-0CBF53764440Q36099076-CC675CBA-642D-4CB8-B998-94959891E854Q36480684-FA42D94D-192D-4924-9892-864E222DF3BAQ37157253-B172CBE0-BD42-4B7D-BAA2-5429849F61D4Q37204595-000CFD9B-2D4B-47B1-AF65-5111A30FF9E6Q37380228-A2126A82-C9DF-421C-8529-D3631DF051C2Q37989143-BB3E2EC4-1E7C-48E1-9C36-DB2E2FCCA20EQ38272835-76EDDD9D-BA9C-4C96-9A87-18C415C220FDQ38725485-42FF6A72-30DC-47F0-AD04-8D3738CA0156Q38880880-C490324E-EE7A-4E4A-BB23-56ECD9B499F6Q40128647-0CC08385-BF3E-4840-A424-2946D3CF7F0AQ41846091-C34E4F5A-4FFE-4351-A204-20CDF1867BE3Q41860564-698ADE68-94D4-4364-82EA-84D85EE3EE24Q48641425-669B8699-4010-4C6C-8CCC-8F2C8B9662C7
P2860
Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Regulation of the interaction ...... ncy-associated nuclear antigen
@en
type
label
Regulation of the interaction ...... ncy-associated nuclear antigen
@en
prefLabel
Regulation of the interaction ...... ncy-associated nuclear antigen
@en
P2093
P2860
P1433
P1476
Regulation of the interaction ...... ncy-associated nuclear antigen
@en
P2093
Hideyoshi Yokosawa
Jianyong Liu
Masahiro Fujimuro
S Diane Hayward
P2860
P304
10429-10441
P356
10.1128/JVI.79.16.10429-10441.2005
P407
P577
2005-08-01T00:00:00Z